Log In
Print this Print this

CR 1493

  Manage Alerts
Collapse Summary General Information
Company Curadis GmbH
DescriptionSelective estrogen beta agonist
Molecular Target Estrogen receptor 2 (ESR2)
Mechanism of ActionEstrogen receptor beta agonist
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationBenign prostatic hyperplasia (BPH)
Indication DetailsTreat benign prostatic hyperplasia (BPH)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today